Panel Discussion: Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients. Actualité hématologique au Canada, Toronto, Canada, v. 1, n. S10, 2022. DOI: 10.58931/cht.2022.1S1029. Disponível em: https://canadianhematologytoday.com/article/view/29. Acesso em: 21 avr. 2026.